Will New Vaccine Recommendations Roll Out?

The CDC’s Advisory Committee is finally meeting to discuss new vaccine recommendations after a long delay. The stakes are high as timely guidance impacts everything from insurance coverage to public health. They’re considering lowering the RSV risk age to 50+, which could save lives and cut healthcare costs by providing earlier protection. But concerningly, flu vaccine votes were removed from the agenda. Let’s hope the committee tackles these critical decisions soon. Delays could mean the difference between widespread protection and leaving high-risk groups vulnerable. #HealthMatters #Vaccines #PublicHealth #CDC #Health